{"id":20791,"date":"2024-11-08T03:59:27","date_gmt":"2024-11-08T03:59:27","guid":{"rendered":"https:\/\/www.ttci-th.org\/?p=20791"},"modified":"2025-03-16T04:09:16","modified_gmt":"2025-03-16T04:09:16","slug":"umanized-antibody-t-cell-leukemia","status":"publish","type":"post","link":"https:\/\/www.ttci-th.org\/th\/umanized-antibody-t-cell-leukemia\/","title":{"rendered":"New Humanized Antibody Targets T-Cell Leukemia with Precision"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"20791\" class=\"elementor elementor-20791\">\n\t\t\t\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-32163b7 elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no\" data-id=\"32163b7\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-9247286\" data-id=\"9247286\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-31ef166 elementor-widget elementor-widget-text-editor\" data-id=\"31ef166\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.16.0 - 14-09-2023 *\/\n.elementor-widget-text-editor.elementor-drop-cap-view-stacked .elementor-drop-cap{background-color:#69727d;color:#fff}.elementor-widget-text-editor.elementor-drop-cap-view-framed .elementor-drop-cap{color:#69727d;border:3px solid;background-color:transparent}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap{margin-top:8px}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap-letter{width:1em;height:1em}.elementor-widget-text-editor .elementor-drop-cap{float:left;text-align:center;line-height:1;font-size:50px}.elementor-widget-text-editor .elementor-drop-cap-letter{display:inline-block}<\/style>\t\t\t\t<p>A new humanized antibody, derived from a mouse antibody, has been engineered to target CD99, a protein overexpressed in T-cell acute lymphoblastic leukemia (T-ALL) and T-lymphoblastic lymphoma (T-LBL). The original mouse antibody was effective at killing leukemia cells but could trigger an immune response in patients. The humanized version is designed to avoid this problem. Studies show that the humanized antibody maintains the ability to bind to CD99 and induce cell death in leukemia cells, while not harming healthy cells. This research offers a promising new avenue for targeted therapy for these aggressive cancers.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-6e75882 elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no\" data-id=\"6e75882\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-16220c7\" data-id=\"16220c7\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-0386e6f elementor-widget elementor-widget-spacer\" data-id=\"0386e6f\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.16.0 - 14-09-2023 *\/\n.elementor-column .elementor-spacer-inner{height:var(--spacer-size)}.e-con{--container-widget-width:100%}.e-con-inner>.elementor-widget-spacer,.e-con>.elementor-widget-spacer{width:var(--container-widget-width,var(--spacer-size));--align-self:var(--container-widget-align-self,initial);--flex-shrink:0}.e-con-inner>.elementor-widget-spacer>.elementor-widget-container,.e-con>.elementor-widget-spacer>.elementor-widget-container{height:100%;width:100%}.e-con-inner>.elementor-widget-spacer>.elementor-widget-container>.elementor-spacer,.e-con>.elementor-widget-spacer>.elementor-widget-container>.elementor-spacer{height:100%}.e-con-inner>.elementor-widget-spacer>.elementor-widget-container>.elementor-spacer>.elementor-spacer-inner,.e-con>.elementor-widget-spacer>.elementor-widget-container>.elementor-spacer>.elementor-spacer-inner{height:var(--container-widget-height,var(--spacer-size))}.e-con-inner>.elementor-widget-spacer.elementor-widget-empty,.e-con>.elementor-widget-spacer.elementor-widget-empty{position:relative;min-height:22px;min-width:22px}.e-con-inner>.elementor-widget-spacer.elementor-widget-empty .elementor-widget-empty-icon,.e-con>.elementor-widget-spacer.elementor-widget-empty .elementor-widget-empty-icon{position:absolute;top:0;bottom:0;left:0;right:0;margin:auto;padding:0;width:22px;height:22px}<\/style>\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-cb58e40 elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no\" data-id=\"cb58e40\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-22372e9\" data-id=\"22372e9\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-d30471e elementor-widget__width-initial elementor-widget elementor-widget-heading\" data-id=\"d30471e\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.16.0 - 14-09-2023 *\/\n.elementor-heading-title{padding:0;margin:0;line-height:1}.elementor-widget-heading .elementor-heading-title[class*=elementor-size-]>a{color:inherit;font-size:inherit;line-height:inherit}.elementor-widget-heading .elementor-heading-title.elementor-size-small{font-size:15px}.elementor-widget-heading .elementor-heading-title.elementor-size-medium{font-size:19px}.elementor-widget-heading .elementor-heading-title.elementor-size-large{font-size:29px}.elementor-widget-heading .elementor-heading-title.elementor-size-xl{font-size:39px}.elementor-widget-heading .elementor-heading-title.elementor-size-xxl{font-size:59px}<\/style><h2 class=\"elementor-heading-title elementor-size-default\">\u0e40\u0e07\u0e34\u0e19\u0e17\u0e38\u0e19<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6aeec7e elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"6aeec7e\" data-element_type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.16.0 - 14-09-2023 *\/\n.elementor-widget-divider{--divider-border-style:none;--divider-border-width:1px;--divider-color:#0c0d0e;--divider-icon-size:20px;--divider-element-spacing:10px;--divider-pattern-height:24px;--divider-pattern-size:20px;--divider-pattern-url:none;--divider-pattern-repeat:repeat-x}.elementor-widget-divider .elementor-divider{display:flex}.elementor-widget-divider .elementor-divider__text{font-size:15px;line-height:1;max-width:95%}.elementor-widget-divider .elementor-divider__element{margin:0 var(--divider-element-spacing);flex-shrink:0}.elementor-widget-divider .elementor-icon{font-size:var(--divider-icon-size)}.elementor-widget-divider .elementor-divider-separator{display:flex;margin:0;direction:ltr}.elementor-widget-divider--view-line_icon .elementor-divider-separator,.elementor-widget-divider--view-line_text .elementor-divider-separator{align-items:center}.elementor-widget-divider--view-line_icon .elementor-divider-separator:after,.elementor-widget-divider--view-line_icon .elementor-divider-separator:before,.elementor-widget-divider--view-line_text .elementor-divider-separator:after,.elementor-widget-divider--view-line_text .elementor-divider-separator:before{display:block;content:\"\";border-bottom:0;flex-grow:1;border-top:var(--divider-border-width) var(--divider-border-style) var(--divider-color)}.elementor-widget-divider--element-align-left .elementor-divider .elementor-divider-separator>.elementor-divider__svg:first-of-type{flex-grow:0;flex-shrink:100}.elementor-widget-divider--element-align-left .elementor-divider-separator:before{content:none}.elementor-widget-divider--element-align-left .elementor-divider__element{margin-left:0}.elementor-widget-divider--element-align-right .elementor-divider .elementor-divider-separator>.elementor-divider__svg:last-of-type{flex-grow:0;flex-shrink:100}.elementor-widget-divider--element-align-right .elementor-divider-separator:after{content:none}.elementor-widget-divider--element-align-right .elementor-divider__element{margin-right:0}.elementor-widget-divider:not(.elementor-widget-divider--view-line_text):not(.elementor-widget-divider--view-line_icon) .elementor-divider-separator{border-top:var(--divider-border-width) var(--divider-border-style) var(--divider-color)}.elementor-widget-divider--separator-type-pattern{--divider-border-style:none}.elementor-widget-divider--separator-type-pattern.elementor-widget-divider--view-line .elementor-divider-separator,.elementor-widget-divider--separator-type-pattern:not(.elementor-widget-divider--view-line) .elementor-divider-separator:after,.elementor-widget-divider--separator-type-pattern:not(.elementor-widget-divider--view-line) .elementor-divider-separator:before,.elementor-widget-divider--separator-type-pattern:not([class*=elementor-widget-divider--view]) .elementor-divider-separator{width:100%;min-height:var(--divider-pattern-height);-webkit-mask-size:var(--divider-pattern-size) 100%;mask-size:var(--divider-pattern-size) 100%;-webkit-mask-repeat:var(--divider-pattern-repeat);mask-repeat:var(--divider-pattern-repeat);background-color:var(--divider-color);-webkit-mask-image:var(--divider-pattern-url);mask-image:var(--divider-pattern-url)}.elementor-widget-divider--no-spacing{--divider-pattern-size:auto}.elementor-widget-divider--bg-round{--divider-pattern-repeat:round}.rtl .elementor-widget-divider .elementor-divider__text{direction:rtl}.e-con-inner>.elementor-widget-divider,.e-con>.elementor-widget-divider{width:var(--container-widget-width,100%);--flex-grow:var(--container-widget-flex-grow)}<\/style>\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-86b218e elementor-widget elementor-widget-text-editor\" data-id=\"86b218e\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p>Chiang Mai University and Fundamental Fund 2024.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-513a232 elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no\" data-id=\"513a232\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-7709a77\" data-id=\"7709a77\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-1fc1ca7 elementor-widget elementor-widget-spacer\" data-id=\"1fc1ca7\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-f5f587e elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no\" data-id=\"f5f587e\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-03bcea0\" data-id=\"03bcea0\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-ca5ef47 elementor-widget__width-initial elementor-widget elementor-widget-heading\" data-id=\"ca5ef47\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">\n\u0e01\u0e23\u0e30\u0e14\u0e32\u0e29\u0e15\u0e49\u0e19\u0e09\u0e1a\u0e31\u0e1a<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-2a9807c elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"2a9807c\" data-element_type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-89bfba8 elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"89bfba8\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p><strong>\u0e0a\u0e37\u0e48\u0e2d\u0e1a\u0e17\u0e04\u0e27\u0e32\u0e21\u0e15\u0e49\u0e19\u0e09\u0e1a\u0e31\u0e1a:<\/strong> Exploring the Biological Activity of a Humanized Anti-CD99 ScFv and Antibody for Targeting T Cell Malignancies.<br \/><strong>\u0e27\u0e32\u0e23\u0e2a\u0e32\u0e23:<\/strong> Biomolecules<br \/><strong>\u0e14\u0e2d\u0e22: <\/strong><a href=\"https:\/\/doi.org\/10.3390\/biom14111422\">https:\/\/doi.org\/10.3390\/biom14111422<\/a><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-2cc934e elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no\" data-id=\"2cc934e\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-9bf8d38\" data-id=\"9bf8d38\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-4b1861f elementor-widget elementor-widget-spacer\" data-id=\"4b1861f\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-5c5d082 elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no\" data-id=\"5c5d082\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-d7e3d8d\" data-id=\"d7e3d8d\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-8a45000 elementor-widget__width-initial elementor-widget elementor-widget-heading\" data-id=\"8a45000\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">\u0e08\u0e14\u0e2b\u0e21\u0e32\u0e22\u0e42\u0e15\u0e49\u0e15\u0e2d\u0e1a<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6aa3269 elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"6aa3269\" data-element_type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-8df055a elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"8df055a\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<ul><li>Watchara Kasinrerk (<a href=\"mailto:watchara.k@cmu.ac.th\">watchara.k@cmu.ac.th<\/a>)<\/li><li>Chatchai Tayapiwatana (<a href=\"mailto:chatchai.t@cmu.ac.th\">chatchai.t@cmu.ac.th<\/a>)<\/li><\/ul>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-a2a0cb4 elementor-section-boxed elementor-section-height-default elementor-section-height-default wpr-particle-no wpr-jarallax-no wpr-parallax-no\" data-id=\"a2a0cb4\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-8067b9b\" data-id=\"8067b9b\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-235d100 elementor-widget elementor-widget-jkit_social_share\" data-id=\"235d100\" data-element_type=\"widget\" data-widget_type=\"jkit_social_share.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<div  class=\"jeg-elementor-kit jkit-social-share jeg_module___6ac08d349df01\" ><ul class=\"social-share-list\"><li class=\"elementor-repeater-item-14d1b21\" data-social=\"facebook\">\n\t\t\t\t<a class=\"facebook social-icon\"><span class=\"icon-position-before\"><i aria-hidden=\"true\" class=\"fab fa-facebook-f\"><\/i>\u0e40\u0e1f\u0e2a\u0e1a\u0e38\u0e4a\u0e04<\/span><\/a>\n\t\t\t<\/li><li class=\"elementor-repeater-item-ee9a855\" data-social=\"twitter\">\n\t\t\t\t<a class=\"twitter social-icon\"><span class=\"icon-position-before\"><i aria-hidden=\"true\" class=\"fab fa-twitter\"><\/i>\u0e17\u0e27\u0e34\u0e15\u0e40\u0e15\u0e2d\u0e23\u0e4c<\/span><\/a>\n\t\t\t<\/li><li class=\"elementor-repeater-item-4a6d796\" data-social=\"line\">\n\t\t\t\t<a class=\"line social-icon\"><span class=\"icon-position-before\"><i aria-hidden=\"true\" class=\"fab fa-line\"><\/i>\u0e40\u0e2a\u0e49\u0e19<\/span><\/a>\n\t\t\t<\/li><\/ul><\/div>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>A new humanized antibody, derived from a mouse antibody, has been engineered to target CD99, a protein overexpressed in T-cell acute lymphoblastic leukemia (T-ALL) and T-lymphoblastic lymphoma (T-LBL). The original mouse antibody was effective at killing leukemia cells but could trigger an immune response in patients. The humanized version is designed to avoid this problem&#8230;.<\/p>","protected":false},"author":4,"featured_media":20345,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[178],"tags":[180],"class_list":["post-20791","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-research-news-cmu","tag-tag-topic-cmu"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.2.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"A new humanized antibody, derived from a mouse antibody, has been engineered to target CD99, a protein overexpressed in T-cell acute lymphoblastic leukemia (T-ALL) and T-lymphoblastic lymphoma (T-LBL). The original mouse antibody was effective at killing leukemia cells but could trigger an immune response in patients. The humanized version is designed to avoid this problem.\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"admin@narisara\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.ttci-th.org\/th\/umanized-antibody-t-cell-leukemia\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.2.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"th_TH\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Thailand Hub of Talents in Cancer Immunotherapy (TTCI Thailand) - TTCI-TH\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"New Humanized Antibody Targets T-Cell Leukemia with Precision\" \/>\n\t\t<meta property=\"og:description\" content=\"A new humanized antibody, derived from a mouse antibody, has been engineered to target CD99, a protein overexpressed in T-cell acute lymphoblastic leukemia (T-ALL) and T-lymphoblastic lymphoma (T-LBL).\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.ttci-th.org\/th\/umanized-antibody-t-cell-leukemia\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2024\/07\/Blue-and-Orange-Modern-Technology-Innovation-and-Information-Systems-Presentation.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2024\/07\/Blue-and-Orange-Modern-Technology-Innovation-and-Information-Systems-Presentation.png\" \/>\n\t\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2024-11-08T03:59:27+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2025-03-16T04:09:16+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/web.facebook.com\/ttci.th\/\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:site\" content=\"@ttci_th\" \/>\n\t\t<meta name=\"twitter:title\" content=\"New Humanized Antibody Targets T-Cell Leukemia with Precision\" \/>\n\t\t<meta name=\"twitter:description\" content=\"A new humanized antibody, derived from a mouse antibody, has been engineered to target CD99, a protein overexpressed in T-cell acute lymphoblastic leukemia (T-ALL) and T-lymphoblastic lymphoma (T-LBL).\" \/>\n\t\t<meta name=\"twitter:creator\" content=\"@ttci_th\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2023\/05\/cropped-cropped-TTCI_LOGO__PNG_-001-removebg-preview.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/umanized-antibody-t-cell-leukemia\\\/#blogposting\",\"name\":\"New Humanized Antibody Targets T-Cell Leukemia with Precision\",\"headline\":\"New Humanized Antibody Targets T-Cell Leukemia with Precision\",\"author\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/author\\\/adminnarisara\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.ttci-th.org\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/Blue-and-Orange-Modern-Technology-Innovation-and-Information-Systems-Presentation.png\",\"width\":1200,\"height\":675},\"datePublished\":\"2024-11-08T03:59:27+00:00\",\"dateModified\":\"2025-03-16T04:09:16+00:00\",\"inLanguage\":\"th\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/umanized-antibody-t-cell-leukemia\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/umanized-antibody-t-cell-leukemia\\\/#webpage\"},\"articleSection\":\"Chiang Mai University, Chiang Mai University\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/umanized-antibody-t-cell-leukemia\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/category\\\/research-news\\\/#listItem\",\"name\":\"Research News\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/category\\\/research-news\\\/#listItem\",\"position\":2,\"name\":\"Research News\",\"item\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/category\\\/research-news\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/category\\\/research-news\\\/research-news-cmu\\\/#listItem\",\"name\":\"Chiang Mai University\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/category\\\/research-news\\\/research-news-cmu\\\/#listItem\",\"position\":3,\"name\":\"Chiang Mai University\",\"item\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/category\\\/research-news\\\/research-news-cmu\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/umanized-antibody-t-cell-leukemia\\\/#listItem\",\"name\":\"New Humanized Antibody Targets T-Cell Leukemia with Precision\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/category\\\/research-news\\\/#listItem\",\"name\":\"Research News\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/umanized-antibody-t-cell-leukemia\\\/#listItem\",\"position\":4,\"name\":\"New Humanized Antibody Targets T-Cell Leukemia with Precision\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/category\\\/research-news\\\/research-news-cmu\\\/#listItem\",\"name\":\"Chiang Mai University\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/#organization\",\"name\":\"Thailand Hub of Talents in Cancer Immunotherapy\",\"description\":\"TTCI-TH\",\"url\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.ttci-th.org\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/cropped-cropped-TTCI_LOGO__PNG_-001-removebg-preview.png\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/umanized-antibody-t-cell-leukemia\\\/#organizationLogo\",\"width\":512,\"height\":512},\"image\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/umanized-antibody-t-cell-leukemia\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/web.facebook.com\\\/ttci.th\\\/\",\"https:\\\/\\\/www.twitter.com\\\/ttci_th\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/author\\\/adminnarisara\\\/#author\",\"url\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/author\\\/adminnarisara\\\/\",\"name\":\"admin@narisara\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/umanized-antibody-t-cell-leukemia\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/75b4fa1780d4337192829073b76451e4e65b3d665abf974c24531ee7367104a4?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"admin@narisara\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/umanized-antibody-t-cell-leukemia\\\/#webpage\",\"url\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/umanized-antibody-t-cell-leukemia\\\/\",\"name\":\"New Humanized Antibody Targets T-Cell Leukemia with Precision\",\"description\":\"A new humanized antibody, derived from a mouse antibody, has been engineered to target CD99, a protein overexpressed in T-cell acute lymphoblastic leukemia (T-ALL) and T-lymphoblastic lymphoma (T-LBL). The original mouse antibody was effective at killing leukemia cells but could trigger an immune response in patients. The humanized version is designed to avoid this problem.\",\"inLanguage\":\"th\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/umanized-antibody-t-cell-leukemia\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/author\\\/adminnarisara\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/author\\\/adminnarisara\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.ttci-th.org\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/Blue-and-Orange-Modern-Technology-Innovation-and-Information-Systems-Presentation.png\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/umanized-antibody-t-cell-leukemia\\\/#mainImage\",\"width\":1200,\"height\":675},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/umanized-antibody-t-cell-leukemia\\\/#mainImage\"},\"datePublished\":\"2024-11-08T03:59:27+00:00\",\"dateModified\":\"2025-03-16T04:09:16+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/#website\",\"url\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/\",\"name\":\"Thailand Hub of Talents in Cancer Immunotherapy\",\"description\":\"TTCI-TH\",\"inLanguage\":\"th\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"New Humanized Antibody Targets T-Cell Leukemia with Precision","description":"A new humanized antibody, derived from a mouse antibody, has been engineered to target CD99, a protein overexpressed in T-cell acute lymphoblastic leukemia (T-ALL) and T-lymphoblastic lymphoma (T-LBL). The original mouse antibody was effective at killing leukemia cells but could trigger an immune response in patients. The humanized version is designed to avoid this problem.","canonical_url":"https:\/\/www.ttci-th.org\/th\/umanized-antibody-t-cell-leukemia\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/www.ttci-th.org\/th\/umanized-antibody-t-cell-leukemia\/#blogposting","name":"New Humanized Antibody Targets T-Cell Leukemia with Precision","headline":"New Humanized Antibody Targets T-Cell Leukemia with Precision","author":{"@id":"https:\/\/www.ttci-th.org\/th\/author\/adminnarisara\/#author"},"publisher":{"@id":"https:\/\/www.ttci-th.org\/th\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2024\/07\/Blue-and-Orange-Modern-Technology-Innovation-and-Information-Systems-Presentation.png","width":1200,"height":675},"datePublished":"2024-11-08T03:59:27+00:00","dateModified":"2025-03-16T04:09:16+00:00","inLanguage":"th","mainEntityOfPage":{"@id":"https:\/\/www.ttci-th.org\/th\/umanized-antibody-t-cell-leukemia\/#webpage"},"isPartOf":{"@id":"https:\/\/www.ttci-th.org\/th\/umanized-antibody-t-cell-leukemia\/#webpage"},"articleSection":"Chiang Mai University, Chiang Mai University"},{"@type":"BreadcrumbList","@id":"https:\/\/www.ttci-th.org\/th\/umanized-antibody-t-cell-leukemia\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.ttci-th.org\/th\/#listItem","position":1,"name":"Home","item":"https:\/\/www.ttci-th.org\/th\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.ttci-th.org\/th\/category\/research-news\/#listItem","name":"Research News"}},{"@type":"ListItem","@id":"https:\/\/www.ttci-th.org\/th\/category\/research-news\/#listItem","position":2,"name":"Research News","item":"https:\/\/www.ttci-th.org\/th\/category\/research-news\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.ttci-th.org\/th\/category\/research-news\/research-news-cmu\/#listItem","name":"Chiang Mai University"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.ttci-th.org\/th\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.ttci-th.org\/th\/category\/research-news\/research-news-cmu\/#listItem","position":3,"name":"Chiang Mai University","item":"https:\/\/www.ttci-th.org\/th\/category\/research-news\/research-news-cmu\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.ttci-th.org\/th\/umanized-antibody-t-cell-leukemia\/#listItem","name":"New Humanized Antibody Targets T-Cell Leukemia with Precision"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.ttci-th.org\/th\/category\/research-news\/#listItem","name":"Research News"}},{"@type":"ListItem","@id":"https:\/\/www.ttci-th.org\/th\/umanized-antibody-t-cell-leukemia\/#listItem","position":4,"name":"New Humanized Antibody Targets T-Cell Leukemia with Precision","previousItem":{"@type":"ListItem","@id":"https:\/\/www.ttci-th.org\/th\/category\/research-news\/research-news-cmu\/#listItem","name":"Chiang Mai University"}}]},{"@type":"Organization","@id":"https:\/\/www.ttci-th.org\/th\/#organization","name":"Thailand Hub of Talents in Cancer Immunotherapy","description":"TTCI-TH","url":"https:\/\/www.ttci-th.org\/th\/","logo":{"@type":"ImageObject","url":"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2023\/05\/cropped-cropped-TTCI_LOGO__PNG_-001-removebg-preview.png","@id":"https:\/\/www.ttci-th.org\/th\/umanized-antibody-t-cell-leukemia\/#organizationLogo","width":512,"height":512},"image":{"@id":"https:\/\/www.ttci-th.org\/th\/umanized-antibody-t-cell-leukemia\/#organizationLogo"},"sameAs":["https:\/\/web.facebook.com\/ttci.th\/","https:\/\/www.twitter.com\/ttci_th\/"]},{"@type":"Person","@id":"https:\/\/www.ttci-th.org\/th\/author\/adminnarisara\/#author","url":"https:\/\/www.ttci-th.org\/th\/author\/adminnarisara\/","name":"admin@narisara","image":{"@type":"ImageObject","@id":"https:\/\/www.ttci-th.org\/th\/umanized-antibody-t-cell-leukemia\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/75b4fa1780d4337192829073b76451e4e65b3d665abf974c24531ee7367104a4?s=96&d=mm&r=g","width":96,"height":96,"caption":"admin@narisara"}},{"@type":"WebPage","@id":"https:\/\/www.ttci-th.org\/th\/umanized-antibody-t-cell-leukemia\/#webpage","url":"https:\/\/www.ttci-th.org\/th\/umanized-antibody-t-cell-leukemia\/","name":"New Humanized Antibody Targets T-Cell Leukemia with Precision","description":"A new humanized antibody, derived from a mouse antibody, has been engineered to target CD99, a protein overexpressed in T-cell acute lymphoblastic leukemia (T-ALL) and T-lymphoblastic lymphoma (T-LBL). The original mouse antibody was effective at killing leukemia cells but could trigger an immune response in patients. The humanized version is designed to avoid this problem.","inLanguage":"th","isPartOf":{"@id":"https:\/\/www.ttci-th.org\/th\/#website"},"breadcrumb":{"@id":"https:\/\/www.ttci-th.org\/th\/umanized-antibody-t-cell-leukemia\/#breadcrumblist"},"author":{"@id":"https:\/\/www.ttci-th.org\/th\/author\/adminnarisara\/#author"},"creator":{"@id":"https:\/\/www.ttci-th.org\/th\/author\/adminnarisara\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2024\/07\/Blue-and-Orange-Modern-Technology-Innovation-and-Information-Systems-Presentation.png","@id":"https:\/\/www.ttci-th.org\/th\/umanized-antibody-t-cell-leukemia\/#mainImage","width":1200,"height":675},"primaryImageOfPage":{"@id":"https:\/\/www.ttci-th.org\/th\/umanized-antibody-t-cell-leukemia\/#mainImage"},"datePublished":"2024-11-08T03:59:27+00:00","dateModified":"2025-03-16T04:09:16+00:00"},{"@type":"WebSite","@id":"https:\/\/www.ttci-th.org\/th\/#website","url":"https:\/\/www.ttci-th.org\/th\/","name":"Thailand Hub of Talents in Cancer Immunotherapy","description":"TTCI-TH","inLanguage":"th","publisher":{"@id":"https:\/\/www.ttci-th.org\/th\/#organization"}}]},"og:locale":"th_TH","og:site_name":"Thailand Hub of Talents in Cancer Immunotherapy (TTCI Thailand) - TTCI-TH","og:type":"article","og:title":"New Humanized Antibody Targets T-Cell Leukemia with Precision","og:description":"A new humanized antibody, derived from a mouse antibody, has been engineered to target CD99, a protein overexpressed in T-cell acute lymphoblastic leukemia (T-ALL) and T-lymphoblastic lymphoma (T-LBL).","og:url":"https:\/\/www.ttci-th.org\/th\/umanized-antibody-t-cell-leukemia\/","og:image":"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2024\/07\/Blue-and-Orange-Modern-Technology-Innovation-and-Information-Systems-Presentation.png","og:image:secure_url":"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2024\/07\/Blue-and-Orange-Modern-Technology-Innovation-and-Information-Systems-Presentation.png","og:image:width":"1200","og:image:height":"675","article:published_time":"2024-11-08T03:59:27+00:00","article:modified_time":"2025-03-16T04:09:16+00:00","article:publisher":"https:\/\/web.facebook.com\/ttci.th\/","twitter:card":"summary_large_image","twitter:site":"@ttci_th","twitter:title":"New Humanized Antibody Targets T-Cell Leukemia with Precision","twitter:description":"A new humanized antibody, derived from a mouse antibody, has been engineered to target CD99, a protein overexpressed in T-cell acute lymphoblastic leukemia (T-ALL) and T-lymphoblastic lymphoma (T-LBL).","twitter:creator":"@ttci_th","twitter:image":"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2023\/05\/cropped-cropped-TTCI_LOGO__PNG_-001-removebg-preview.png"},"aioseo_meta_data":{"post_id":"20791","title":"#post_title","description":null,"keywords":[],"keyphrases":{"focus":{"keyphrase":"Humanized Antibody ","score":68,"analysis":{"keyphraseInTitle":{"score":9,"maxScore":9,"error":0},"keyphraseInDescription":{"score":9,"maxScore":9,"error":0},"keyphraseLength":{"score":9,"maxScore":9,"error":0,"length":2},"keyphraseInURL":{"score":1,"maxScore":5,"error":1},"keyphraseInIntroduction":{"score":9,"maxScore":9,"error":0},"keyphraseInSubHeadings":{"score":3,"maxScore":9,"error":1},"keyphraseInImageAlt":[],"keywordDensity":{"score":0,"type":"low","maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":"A new humanized antibody, derived from a mouse antibody, has been engineered to target CD99, a protein overexpressed in T-cell acute lymphoblastic leukemia (T-ALL) and T-lymphoblastic lymphoma (T-LBL).","og_object_type":"default","og_image_type":"featured","og_image_url":"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2024\/07\/Blue-and-Orange-Modern-Technology-Innovation-and-Information-Systems-Presentation.png","og_image_width":"1200","og_image_height":"675","og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":[],"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"BlogPosting","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"limit_modified_date":false,"created":"2025-03-16 04:04:23","updated":"2026-09-03 07:13:28","focus_keyword":"Humanized Antibody","additional_keywords":null,"truseo_locale":null,"ai":null,"breadcrumb_settings":null,"seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.ttci-th.org\/th\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.ttci-th.org\/th\/category\/research-news\/\" title=\"Research News\">Research News<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.ttci-th.org\/th\/category\/research-news\/research-news-cmu\/\" title=\"Chiang Mai University\">Chiang Mai University<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tNew Humanized Antibody Targets T-Cell Leukemia with Precision\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.ttci-th.org\/th\/"},{"label":"Research News","link":"https:\/\/www.ttci-th.org\/th\/category\/research-news\/"},{"label":"Chiang Mai University","link":"https:\/\/www.ttci-th.org\/th\/category\/research-news\/research-news-cmu\/"},{"label":"New Humanized Antibody Targets T-Cell Leukemia with Precision","link":"https:\/\/www.ttci-th.org\/th\/umanized-antibody-t-cell-leukemia\/"}],"_links":{"self":[{"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/posts\/20791","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/comments?post=20791"}],"version-history":[{"count":0,"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/posts\/20791\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/media\/20345"}],"wp:attachment":[{"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/media?parent=20791"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/categories?post=20791"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/tags?post=20791"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}